⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biomed Industries, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Biomed Industries, Inc.
↗San Jose, USA
Biomed Industries, Inc. is a clinical-stage biopharmaceutical company based in Silicon Valley. The company focuses on developing novel therapeutics for unmet medical needs, particularly in neurodegenerative diseases, metabolic disorders, and rare diseases, leveraging its proprietary Unified Acceleration Platform (UAP) and AI-driven drug discovery.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2009
Ownership:private
Status:operating
PIPELINE
Stage:Phase 2/3
Lead Drug Stage:Phase 3
Modalities:Small molecule
Active Trials:6
Trial Phases:Phase 2: 3 | Phase 3: 3
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Biomed Pharmaceuticals, Inc., NeuroActiva, Inc., BiomedAI, LLC, Biomed Digital, LLC, MedAware Systems, Inc.
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Lloyd L. Tran - Chairman and CSO
Michael Willis - Vice President of Business Development
Scientific Founders:Lloyd L. Tran
LINKS
Website:biomedind.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biomed Industries, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.